These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4182063)
21. [Treatment of acute pancreatitis and cholecystopancreatitis with trasylol]. Shabanov AN; Mikeladze KD Vestn Khir Im I I Grek; 1972 Jan; 107(1):41-4. PubMed ID: 4539002 [No Abstract] [Full Text] [Related]
22. [Coagulation inhibiting effect of Trasylol]. Slunsky R Z Geburtshilfe Gynakol; 1971 Aug; 175(1):55-61. PubMed ID: 5315177 [No Abstract] [Full Text] [Related]
23. Effects of aprotinin on postoperative bleeding. Merle JP; Lançon JP; Dutrillaux F; Obadia JF; Caillard B Anesthesiology; 1991 Aug; 75(2):379-80. PubMed ID: 1713429 [No Abstract] [Full Text] [Related]
24. [Animal experiments on influencing post-operative adhesions in the surgery of tendons (author's transl)]. Gay B Z Orthop Ihre Grenzgeb; 1974 Oct; 112(5):1029-35. PubMed ID: 4280824 [No Abstract] [Full Text] [Related]
29. [Use of Trasylol in acute pancreatitis]. Kubangaleev SM; Eletskaia OI Klin Med (Mosk); 1969 Apr; 47(4):63-8. PubMed ID: 5308980 [No Abstract] [Full Text] [Related]
30. Management of the thrombocytopenic cardiac surgical patient--a role for aprotinin? Whitten CW; Allison PM; Latson TW; Bossard RF; Rosenberg JA; Ring WS Anesth Analg; 1994 Oct; 79(4):796-800. PubMed ID: 7524377 [No Abstract] [Full Text] [Related]
31. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. Havel M; Grabenwöger F; Schneider J; Laufer G; Wollenek G; Owen A; Simon P; Teufelsbauer H; Wolner E J Thorac Cardiovasc Surg; 1994 Mar; 107(3):807-10. PubMed ID: 7510351 [TBL] [Abstract][Full Text] [Related]
32. Aprotinin therapy as prophylaxis against postoperative pancreatitis in humans. A controlled evaluation. Skinner DB; Corson JG; Nardi GL JAMA; 1968 Jun; 204(11):945-8. PubMed ID: 5300957 [No Abstract] [Full Text] [Related]
33. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Fritz H; Wunderer G Arzneimittelforschung; 1983; 33(4):479-94. PubMed ID: 6191764 [TBL] [Abstract][Full Text] [Related]
34. The current place of aprotinin in the management of bleeding. Royston D Anaesthesia; 2015 Jan; 70 Suppl 1():46-9, e17. PubMed ID: 25440394 [TBL] [Abstract][Full Text] [Related]
35. [Prevention and treatment of edema due to arterial revascularization]. Agus GB; Trezzi M; Zanetta M Minerva Chir; 1975 Feb; 30(3):139-42. PubMed ID: 1090860 [TBL] [Abstract][Full Text] [Related]
36. [Trasylol in hyperfibrinolytic conditions]. Ludwig H Langenbecks Arch Chir; 1969; 325():358-61. PubMed ID: 5309041 [No Abstract] [Full Text] [Related]
37. Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol. Glauber M; Szefner J; Senni M; Gamba A; Mamprin F; Fiocchi R; Somaschini M; Ferrazzi P Int J Artif Organs; 1995 Oct; 18(10):649-55. PubMed ID: 8647598 [TBL] [Abstract][Full Text] [Related]
38. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin. Klein M; Keith PR; Dauben HP; Schulte HD; Beckmann H; Mayer G; Elert O; Gams E Eur J Cardiothorac Surg; 1998 Oct; 14(4):360-6. PubMed ID: 9845139 [TBL] [Abstract][Full Text] [Related]
39. The influence of aprotinin (Trasylol) on experimental acute necrosis of the pancreas in rats. Dembińska-Kieć A Acta Med Pol; 1972; 13(1):1-28. PubMed ID: 4544454 [No Abstract] [Full Text] [Related]